Tough guidelines proposed for genetic breast cancer test
This article was originally published in Clinica
Executive Summary
An ethics panel in the US has called for strict guidelines to ensure that genetic tests for breast cancer are only used on patients who will benefit from the information they provide. Testing for BRCA1 and BRCA2 mutations should not be used on most women and marketing of these tests should be strictly limited, the panel said.